Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms

Area of Science:

• Molecular Biology
• Hematology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial regulators of gene expression at posttranscriptional and translational levels.
• Dysregulation of miRNAs is implicated in various hematologic disorders, including thrombocytosis.
• Understanding miRNA roles in megakaryocytopoiesis and platelet biology is essential for disease insights.

Purpose of the Study:

• To identify miRNA expression patterns associated with thrombocytosis.
• To define a specific miRNA signature for essential thrombocythemia (ET).
• To investigate the functional role of novel miRNAs and their targets in megakaryocyte and platelet regulation.

Main Methods:

• Analysis of miRNA expression in 79 subjects with thrombocytosis and controls.
• Integration of transcriptomic and proteomic data.
• Functional reporter assays and overexpression studies in progenitor cell models.
• Mass spectrometry to identify protein targets.

Main Results:

• A unique 21-miRNA genetic fingerprint associated with thrombocytosis was validated.
• A 3-miRNA subset, including miR 490 (5p and 3p), was identified as defining ET.
• miR 490 showed aberrant expression in megakaryocytes/platelets during thrombocytosis, particularly in ET.
• Dishevelled associated activator of morphogenesis 1 (DAAM1) was identified as a miR 490 5p target, with decreased expression in ET platelets via translational control.

Conclusions:

• A dysregulated miRNA fingerprint characterizes thrombocytosis.
• miR 490 and its DAAM1 target play a role in conditions with exaggerated megakaryocytopoiesis and proplatelet formation.
• These findings offer potential diagnostic and therapeutic targets for thrombocytosis and ET.